BC Innovations | Apr 7, 2011
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Melanoma NUAK family SNF1-like kinase 2 (NUAK2) Studies in mice and in patient samples suggest that inhibiting NUAK2 could help treat acral lentiginous melanoma,...
Items per page:
1 - 1 of 1